GNE-9815
GNE-9815
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name GNE-9815
CAS2729996-45-4
FormulaC26H22FN5O2
MW455.48
AppearanceOff-white to light yellow powder
Storage conditionStore in a dry and dark sealed container, short-term (weeks to months) storage at 0-4 ℃, long-term (months to years) storage at -20 ℃.
Security information
Product details

GNE-9815 (compound 7) is a highly selective, orally bioavailable pan-RAF inhibitor. For CRAF and BRAF, respectively, GNE-9815 displays Ki values of 0.062 and 0.19 nM. The MAPK pathway is modulated synergistically when GNE-9815 and the MEK inhibitor Cobimetinib are combined. Cancers with the KRAS mutation can be studied using GNE-9815.

Related literature
Related
Sorry, no related items
History
Fexagratinib (Synonyms: AZD4547; ADSK091;AZD-4547)
Libivirumab
GNE-9815
BIO (GSK-3 Inhibitor IX | 6-bromoindirubin-3-oxime | 6-Bromoindirubin-3'-oxime | MLS 2052 | (2'Z,3'E)-6-Bromoindirubin-3'-oxime | 6-BIO | 6BIO
TAK-715
Rubranol
Crenolanib | CP-868596 | ARO 002
Virgaureagenin G | Polygalacic acid
Desbutyl Lumefantrine | Desbutyl-benflumetol | (Z)-Desbutyl Lumefantrine
ST 1535